Analysis of the Efficacy of Budesonide Combined with Terbutaline Inhala-tion in the Adjuvant Treatment of Mycoplasma Pneumonia
Objective To analyze the efficacy of budesonide combined with terbutaline inhalation in the treatment of mycoplasma pneumonia.Methods The clinical data of 86 children with mycoplasma pneumoniae pneumonia admitted to Dehua County Hospital from January 2022 to October 2023 were retrospectively selected.They were divided into treatment group(azithromycin combined with budesonide and terbutaline atomization inhalation)and control group(azithromycin)according to different treatment methods,with 43 cases in each group.The efficacy,symptom disappear-ance time,the level of serum C-reactive protein and white blood cell in children in two groups after treatment were analyzed.Results The total effective rate of clinical treatment in the treatment group was 93.02%(40/43),which was higher than 83.72%(36/43)in the control group,and the difference was statistically significant(χ2=4.208,P<0.05).The disappearance time of fever,cough and pulmonary rales in the treatment group were(3.91±1.81)d,(6.53±1.56)d and(6.33±2.60)d,which were all shorter than(4.79±1.47)d,(7.88±2.16)d and(7.56±2.44)d in the control group,and the differences were statistically significant(t=2.483,3.314,2.267,all P<0.05).After treatment,the levels of se-rum C-reactive protein and white blood cells in the treatment group were lower than those in the control group,and the differences were statistically significant(both P<0.05).Conclusion Terbutaline aerosol inhalation adjuvant therapy in the treatment of mycoplasma pneumoniae pneumonia can relieve symptoms faster,improve clinical efficacy,and re-duce inflammation in the body.
NETL
NSTL
万方数据
